Nordwand Advisors’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Nordwand Advisors’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500	Closed	-$1.35K	–	135
2023 Q1	$1.35K	Buy	+500	New	+$1.91K	﹤0.01%	121

Nordwand Advisors's HTGM Position: Q2 2023 in Review

Nordwand Advisors sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q2 2023, closing a stake of 500 shares — an estimated $1.35K sold.

Nordwand Advisors first reported a position in HTGM in Q1 2023 and held it in 1 quarter. The position peaked at $1.35K in Q1 2023. 0 funds tracked by Wall St. Rank hold HTGM as of Q2 2023.

Nordwand Advisors reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Nordwand Advisors sold 500 HTG Molecular Diagnostics, Inc. Common Stock shares in Q2 2023, an estimated $1.35K.
Nordwand Advisors first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Nordwand Advisors's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $1.35K in Q1 2023.
0 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q2 2023.

Based on Nordwand Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.